Zhejiang Gongdong Medical Technology Co.,Ltd. (605369.SS)
CNY 29.34
(-0.47%)
CNY 29.34
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 185.39 Million | 282.75 Million | 372.98 Million | 242.18 Million | 122.33 Million | 102.42 Million |
| Net Income | 109.12 Million | 326.04 Million | 310.98 Million | 225.88 Million | 113.58 Million | 84.92 Million |
| Depreciation & Amortization | 83.98 Million | 41.23 Million | 21.8 Million | 18.9 Million | 16.4 Million | 12.8 Million |
| Deferred income taxes | 1.21 Million | 1.6 Million | 5.29 Million | -450.99 Thousand | -165.6 Thousand | -179.3 Thousand |
| Stock-based compensation | 2.69 Million | 19.06 Million | 12.79 Million | - | - | 1.91 Million |
| Change in working capital | -18.45 Million | -86.61 Million | 25.48 Million | -19.01 Million | -9.54 Million | 1.24 Million |
| Other non-cash items | 7.36 Million | -19.43 Million | -3.38 Million | 16.4 Million | 1.88 Million | 3.44 Million |
| Investing Cash Flow | -397.42 Million | -163.1 Million | -316.69 Million | -148.96 Million | -100.65 Million | -35.65 Million |
| Investments in PPE | -121.82 Million | -172.18 Million | -275.55 Million | -108.57 Million | -102.29 Million | -35.86 Million |
| Acquisitions | -275.58 Million | 50.15 Thousand | 11.84 Million | 84.73 Thousand | 103.11 Million | - |
| Investment purchases | -11.17 Million | -161.79 Million | -289.64 Million | -159 Million | -124 Million | -94.4 Million |
| Sales/Maturities of investments | 11.14 Million | 213.58 Million | 244.64 Million | 121.13 Million | 124.82 Million | 94.35 Million |
| Other Investing Activities | -22.12 Thousand | -42.76 Million | -7.98 Million | -2.6 Million | -102.29 Million | 265.7 Thousand |
| Financing Cash Flow | -95.8 Million | -155.12 Million | -113.47 Million | 577.19 Million | -92.93 Million | 29.74 Million |
| Debt repayment | -5.11 Million | -691.77 Thousand | -345.88 Thousand | - | -70 Million | -16.33 Million |
| Dividends payments | -90.09 Million | -155.42 Million | -144 Million | - | -50.68 Million | -255.38 Thousand |
| Common Stock Repurchased | -589.56 Thousand | -685.93 Thousand | - | - | - | - |
| Common Stock Issuance | - | 1.37 Million | - | - | - | - |
| Other Financing Activities | -5.7 Million | 299.01 Thousand | 30.87 Million | 577.19 Million | 27.75 Million | 46.32 Million |
| Accounts receivables | -4.35 Million | -53.48 Million | -45.65 Million | -57.76 Million | -29.99 Million | -19.16 Million |
| Accounts payables | -19.06 Million | -22.7 Million | 117.54 Million | 64.11 Million | 28.6 Million | 18.86 Million |
| Inventory | 3.74 Million | -12.02 Million | -51.69 Million | -24.91 Million | -7.99 Million | 1.72 Million |
| Other working capital | 2.87 Million | 1.6 Million | 5.29 Million | -450.99 Thousand | -165.59 Thousand | -480.79 Thousand |
| Cash at beginning of period | 703.23 Million | 707.82 Million | 770.76 Million | 115.31 Million | 186.47 Million | 87.56 Million |
| Cash at end of period | 397.67 Million | 703.23 Million | 707.82 Million | 770.76 Million | 115.31 Million | 186.47 Million |
| Capital Expenditure | -121.82 Million | -172.18 Million | -275.55 Million | -108.57 Million | -102.29 Million | -35.86 Million |
| Effect of forex changes on cash | 2.28 Million | 30.88 Million | -5.75 Million | -14.97 Million | 103.91 Thousand | 2.39 Million |
| Net cash flow / Change in cash | -305.55 Million | -4.59 Million | -62.93 Million | 655.44 Million | -71.15 Million | 98.91 Million |
| Free Cash Flow | 63.56 Million | 110.56 Million | 97.42 Million | 133.6 Million | 20.03 Million | 66.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.1 Million | 50.18 Million | 45.1 Million | 20.87 Million | 109.12 Million | 27.29 Million |
| Depreciation & Amortization | - | 22.17 Million | 22.17 Million | 83.98 Million | 83.98 Million | -36.8 Million |
| Deferred income taxes | - | - | - | - | 1.21 Million | 68.98 Million |
| Stock-based compensation | - | 1.46 Million | - | -909.08 Thousand | 2.69 Million | -909.08 Thousand |
| Change in working capital | - | -26.46 Million | - | 2.27 Million | -18.45 Million | -27.8 Million |
| Other non-cash items | 19.8 Million | 11.84 Million | -4.04 Million | -35.63 Million | 7.36 Million | 7.12 Million |
| Investing Cash Flow | -42.66 Million | 35.33 Million | -24.12 Million | -46.27 Million | -397.42 Million | -10.82 Million |
| Investments in PPE | -42.56 Million | -14.69 Million | -14.08 Million | -59.56 Million | -121.82 Million | -9.6 Million |
| Acquisitions | 4000.00 | 20.8 Thousand | - | -275.58 Million | -275.58 Million | -10.99 Million |
| Investment purchases | -11.1 Million | - | -11 Million | 288.87 Million | -11.17 Million | -12.36 Million |
| Sales/Maturities of investments | 11 Million | 402.8 Thousand | 956.55 Thousand | - | 11.14 Million | 11 Million |
| Other Investing Activities | - | 50 Million | -10.04 Million | 288.87 Million | -22.12 Thousand | 11.14 Million |
| Financing Cash Flow | 412.15 Thousand | -2.14 Million | -1.62 Million | -61.06 Million | -95.8 Million | -617.48 Thousand |
| Debt repayment | - | - | - | - | -5.11 Million | - |
| Dividends payments | - | - | - | -56.3 Million | -90.09 Million | -28.15 Million |
| Common Stock Repurchased | 3.02 Million | -3.02 Million | - | -589.56 Thousand | -589.56 Thousand | -294.78 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.6 Million | 1.62 Million | -1.62 Million | -4.75 Million | -5.7 Million | -617.48 Thousand |
| Accounts receivables | - | -45.36 Million | - | -4.35 Million | -4.35 Million | -14.34 Million |
| Accounts payables | - | - | - | - | -19.06 Million | 4.51 Million |
| Inventory | - | 18.9 Million | - | 3.74 Million | 3.74 Million | -13.45 Million |
| Other working capital | - | - | - | 2.87 Million | 2.87 Million | -4.51 Million |
| Cash at beginning of period | 490.11 Million | 463.48 Million | 397.67 Million | 447.83 Million | 703.23 Million | 412.47 Million |
| Cash at end of period | 502.87 Million | 490.11 Million | 413.48 Million | 397.67 Million | 397.67 Million | 447.83 Million |
| Capital Expenditure | -42.56 Million | -14.69 Million | -14.08 Million | -59.56 Million | -121.82 Million | -9.6 Million |
| Effect of forex changes on cash | - | 3.59 Million | 490.56 Thousand | -14.32 Million | 2.28 Million | 12.52 Million |
| Net cash flow / Change in cash | 12.75 Million | 26.63 Million | 15.8 Million | -50.16 Million | -305.55 Million | 35.36 Million |
| Free Cash Flow | 23.34 Million | 25.16 Million | 26.98 Million | 11.93 Million | 63.56 Million | 24.67 Million |
IFINSER
603648
300261
CLCS
PIRC
IXRRF